Upon further investigations, it was found that the protective effects of the extracts are via regulation of the FXR/SHP/SREBP-1c pathway (farnesoid X receptor/small heterodimer partner/sterol regulatory element-binding protein-1c), hence giving rise to their anti-NAFLD and hepatoprotective capabilities. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.